CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-01 | Biller Jonathan Chief Financial Officer | Grant or award · Restricted stock units | +11,500 | 11,500 | ||
| 2022-03-01 | Biller Jonathan Chief Financial Officer | Grant or award · Stock options (right to buy) | +41,000 | 41,000 | ||
| 2022-02-22 | Biller Jonathan Chief Financial Officer | Shares withheld for taxes | −2,688 | $29.08 | $78K | 22,953 |
| 2022-02-18 | Biller Jonathan Chief Financial Officer | Exercise or conversion | +8,523 | 25,641 | ||
| 2022-02-18 | Biller Jonathan Chief Financial Officer | Exercise or conversion · Performance share units | −8,523 | 8,522 | ||
| 2022-02-10 | Biller Jonathan Chief Financial Officer | Exercise or conversion | +3,667 | 18,467 | ||
| 2022-02-10 | Biller Jonathan Chief Financial Officer | Shares withheld for taxes | −1,349 | $31.43 | $42K | 17,118 |
| 2022-02-10 | Biller Jonathan Chief Financial Officer | Exercise or conversion · Restricted stock units | −3,667 | 7,333 | ||
| 2021-12-03 | Biller Jonathan Chief Financial Officer | Exercise or conversion | +5,753 | 16,623 | ||
| 2021-12-03 | Biller Jonathan Chief Financial Officer | Shares withheld for taxes | −1,823 | $35.88 | $65K | 14,800 |
| 2021-12-03 | Biller Jonathan Chief Financial Officer | Exercise or conversion · Restricted stock units | −5,753 | 5,753 | ||
| 2021-02-10 | Biller Jonathan Chief Financial Officer | Grant or award · Restricted stock units | +11,000 | 11,000 | ||
| 2021-02-10 | Biller Jonathan Chief Financial Officer | Grant or award · Stock option (right to buy) | +44,000 | 44,000 | ||
| 2020-12-03 | Biller Jonathan Chief Financial Officer | Exercise or conversion | +5,753 | 11,747 | ||
| 2020-12-03 | Biller Jonathan Chief Financial Officer | Shares withheld for taxes | −1,707 | $45.87 | $78K | 10,040 |
| 2020-12-03 | Biller Jonathan Chief Financial Officer | Exercise or conversion · Restricted stock units | −5,753 | 11,506 | ||
| 2020-04-14 | Biller Jonathan Chief Legal Officer | Shares withheld for taxes | −2,529 | $40.64 | $103K | 5,994 |
| 2020-04-13 | Biller Jonathan Chief Legal Officer | Exercise or conversion | +8,523 | 8,523 | ||
| 2020-04-13 | Biller Jonathan Chief Legal Officer | Exercise or conversion · Performance share units | −8,523 | 17,045 | ||
| 2019-12-03 | Biller Jonathan Chief Legal Officer | Grant or award · Stock option (right to buy) | +78,824 | 78,824 |
Page 1 of 2 · 21 trades